Saranas logo — Give Bleeding the Bird

Saranas

Give Bleeding the Bird

Founded 2013 United States Houston, United States 10 employees Series B Health Care, Medical Devices

General Information

Company Name Saranas
Founded Year 2013
Location United States Houston, United States
Employees 10
Industries Health Care, Medical Devices
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Saranas. To contact Saranas, visit saranas.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Saranas

Saranas is a health care and medical devices startup founded in 2013. The company has developed the Early Bird Bleed Monitoring System, a technology designed for the early detection and monitoring of bleeding complications associated with vascular access procedures. The system includes a vascular access sheath with embedded sensors that measure the electrical resistance across the blood vessel. In the event of accidental injury during endovascular procedures, such as transcatheter aortic valve replacement, large bore hemodynamic support device placement, or other complex cardiac interventions, the Early Bird is designed to detect and monitor bleeding from the blood vessel. The invention originated from the Texas Heart Institute. The most recent milestone for Saranas was the Series B investment on 19 July 2021, which signifies a notable achievement for the company in terms of investor confidence and capital growth. The visibility and potential of the Early Bird system have likely attracted interest from venture capitalists and strategic investors. However, there is no specific information available regarding the latest investment's investors. In conclusion, Saranas has positioned itself as a promising contender within the medical devices industry with its innovative technology aimed at addressing critical bleeding complications during vascular access procedures. The recent Series B investment is indicative of the industry's recognition of the company's potential impact and the value of its technological advancements.

Taxonomy: Interventional Cardiology, Electrophysiology, Vascular Surgery, Interventional Radiology, Critical Care, Bleed Monitoring, Catheterization Procedures, Cardiac Interventions, Vascular Access, Internal Bleeding Detection, Surgical Complications, Medical Procedure Monitoring

No funding data available for Saranas yet.

Saranas Alternatives & Competitors

Saranas vs

Our Mission : Leverage Artificial Intelligence to revolutionize interventional cardiac electrophysio...

Series B
116 employees
AI, Health Care
Saranas vs

Pioneering the future of vascular interventional surgery with our advanced coronary angiography syst...

Series D
10 employees
Health Care, Medical Devices
Saranas vs

Innovative access devices for a more efficient and pleasant cath lab and post-procedure experience.

Venture round
Health Care, Manufacturing

FAQ About Saranas

Give Bleeding the Bird
Saranas was founded in 2013.
Saranas is headquartered in Houston, United States.
Saranas operates in Health Care and Medical Devices. Its work centres on Interventional Cardiology, Electrophysiology, Vascular Surgery and Interventional Radiology.
Saranas has approximately 10 employees.
Top alternatives and competitors to Saranas include Volta Medical, 苏州润迈德医疗科技有限公司, Arstasis, VeinWay Ltd., EKOS Corporation. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Saranas and Volta Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Saranas, https://bouncewatch.com/company/saranas, updated 30 July 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes